Management ChangeMay 12, 2026, 08:17 AM
AC Immune CEO Dr. Andrea Pfeifer to retire; Board Chair Martin Zügel interim CEO
AI Summary
AC Immune SA announced that its co-founder and CEO, Dr. Andrea Pfeifer, will retire from her role at the upcoming Annual General Meeting after 23 years. Dr. Martin Zügel, the current Board Chair, has been appointed interim CEO while the company conducts a search for a permanent successor. Dr. Pfeifer will remain involved as an Advisor, Honorary Chair of the Board, and Co-Chair of the Scientific Advisory Board to facilitate a smooth transition. The company emphasized its strong financial position and pipeline, including three clinical-stage candidates and strategic partnerships.
Key Highlights
- Co-founder and CEO, Dr. Andrea Pfeifer, to retire after 23 years at the upcoming AGM.
- Board Chair, Dr. Martin Zügel, appointed interim CEO during the search for a permanent successor.
- Dr. Pfeifer will serve as an Advisor, Honorary Chair of the Board, and Co-Chair of the Scientific Advisory Board.
- Company highlights a robust balance sheet and multiple near-term value-inflection milestones.
- AC Immune has three Precision Prevention candidates in the clinic and strategic partnerships.